Market by Therapy Type, Type of Disease, Route of Administration, and Country | Forecast 2021-2028
Triton’s report infers that the Latin American hormone replacement therapy market is likely to register growth at a CAGR of 6.97% during the estimated period 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries analyzed in this
market include:
• Brazil
• Mexico
• Rest of Latin America
In Latin America, the demand
for estrogen replacement is anticipated to be driven by the wide range of
target population bases across the region’s nations. Moreover, the rising focus
of the governments on women’s healthcare is also estimated to positively impact
the progress of the reviewed market over the considered period.
In Mexico, the rising
population base and surge in healthcare spending have significantly supported the
growth of the hormone replacement therapy market. Moreover, universal
healthcare coverage is considered to be among the most comprehensive health
schemes transforming the country’s healthcare infrastructure. Furthermore,
earlier, Mexico spent a significant amount on an individual’s healthcare. Thus,
such developments in the healthcare sector are anticipated to offer several new
opportunities to the Mexican hormone replacement therapy market over the
considered period.
Brazil, for instance,
showcases potential growth due to the recent focus of the government on the testosterone
issue. Here, testosterone replacement is widely approved to treat male
hypogonadism. Furthermore, transgender people are considered to be highly
susceptible to gender dysphoria, requiring testosterone hormone therapy. This essentially
supports the market’s growth across the country. Above all, similar to Mexico,
the increase in healthcare expenditure by the government is fueling the
expansion of the hormone replacement therapy market within Brazil to a large
extent.
Pfizer Inc is a
biopharmaceutical company engaged in discovering, manufacturing, and
distributing various products, including medicines, vaccines, and consumer
healthcare products. It primarily provides its products to treat conditions
like respiratory, cardiovascular, women’s health issues, genitourinary
infections, and others. Premarin is one of the medicines offered by Pfizer that
consists of a mixture of estrogen hormones. The company has operations across
multiple regions, including Latin America.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA HORMONE REPLACEMENT THERAPY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON HORMONE REPLACEMENT THERAPY MARKET
2.2. KEY
INSIGHTS
2.2.1. INTRODUCTION
OF NEW DRUG DELIVERY SYSTEMS FOR HORMONE REPLACEMENT
2.2.2. MODERN
SEDENTARY LIFESTYLES
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
STRATEGIC DEVELOPMENTS
2.6.1. ACQUISITIONS
& MERGERS
2.6.2. PRODUCT
LAUNCH & DEVELOPMENTS
2.6.3. CONTRACTS
AND PARTNERSHIPS
2.6.4. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
2.7. MARKET
DRIVERS
2.7.1. RISE
IN AWARENESS PERTAINING TO HEALTH PROBLEMS DURING MENOPAUSE
2.7.2. INCREASE
IN PREVALENCE OF HORMONAL DISORDERS
2.7.3. NEW
PRODUCT LAUNCHES BY MAJOR GIANTS
2.8. MARKET
RESTRAINTS
2.8.1. HIGH
COST OF TREATMENT
2.8.2. ADVERSE
REACTIONS ASSOCIATED WITH HORMONE REPLACEMENT THERAPY
2.9. MARKET
OPPORTUNITIES
2.9.1. AVAILABILITY
OF ALTERNATIVE THERAPY OFFERS OPPORTUNITIES FOR THE MARKET’S GROWTH
2.9.2. LAUNCH
OF TELEMEDICINE CLINICAL PRACTICE SERVICES
3. LATIN
AMERICA HORMONE REPLACEMENT THERAPY MARKET - BY THERAPY TYPE
3.1. ESTROGEN
HORMONE REPLACEMENT THERAPY
3.2. THYROID
HORMONE REPLACEMENT THERAPY
3.3. TESTOSTERONE
HORMONE REPLACEMENT THERAPY
3.4. HUMAN
GROWTH HORMONE REPLACEMENT THERAPY
3.5. PROGESTOGEN
HORMONE REPLACEMENT THERAPY
4. LATIN
AMERICA HORMONE REPLACEMENT THERAPY MARKET - BY TYPE OF DISEASE
4.1. MENOPAUSE
4.2. MALE
HYPOGONADISM
4.3. GROWTH
HORMONE DEFICIENCY
4.4. HYPOTHYROIDISM
4.5. OTHER
TYPE OF DISEASES
5. LATIN
AMERICA HORMONE REPLACEMENT THERAPY MARKET - BY ROUTE OF ADMINISTRATION
5.1. ORAL
5.2. PARENTERAL
5.3. TRANSDERMAL
5.4. OTHER
ROUTES OF ADMINISTRATION
6. LATIN
AMERICA HORMONE REPLACEMENT THERAPY INDUSTRY – COUNTRY OUTLOOK
6.1. MEXICO
6.2. BRAZIL
6.3. REST
OF LATIN AMERICA
7. COMPETITIVE
LANDSCAPE
7.1. ABBOTT
LABORATORIES
7.2. AMGEN
7.3. ANI
PHARMACEUTICALS
7.4. BAYER
AG
7.5. DR
REDDY’S LABORATORIES LTD
7.6. ELI
LILLY & COMPANY
7.7. GENENTECH
INC
7.8. IPSEN
7.9. MERCK
KGAA
7.10. NOVARTIS
AG
7.11. NOVEN
PHARMACEUTICALS INC
7.12. NOVO
NORDISK A/S
7.13. PFIZER
INC
7.14. TEVA
PHARMACEUTICAL INDUSTRIES LTD
7.15. VIATRIS
INC (MYLAN NV)
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: LATIN AMERICA HORMONE REPLACEMENT THERAPY
MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS & MERGERS
TABLE 4: LIST OF PRODUCT LAUNCHES &
DEVELOPMENTS
TABLE 5: LIST OF CONTRACTS AND PARTNERSHIPS
TABLE 6: LATIN AMERICA HORMONE REPLACEMENT THERAPY
MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 7: LATIN AMERICA HORMONE REPLACEMENT THERAPY
MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE 8: LATIN AMERICA HORMONE REPLACEMENT THERAPY
MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE 9: LATIN AMERICA HORMONE REPLACEMENT THERAPY
MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)
FIGURE 1: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2020 & 2028 (IN %)
FIGURE 3: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028
(IN $ MILLION)
FIGURE 4: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028
(IN $ MILLION)
FIGURE 5: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 6: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 7: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 8: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2020 & 2028 (IN %)
FIGURE 9: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)
FIGURE 10: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)
FIGURE 11: LATIN AMERICA HORMONE REPLACEMENT
THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $ MILLION)
FIGURE 12: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)
FIGURE 13: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY OTHER TYPE OF DISEASES, 2021-2028 (IN $ MILLION)
FIGURE 14: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2028 (IN %)
FIGURE 15: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
FIGURE 16: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)
FIGURE 17: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)
FIGURE 18: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY OTHER ROUTES OF ADMINISTRATION, 2021-2028 (IN $
MILLION)
FIGURE 19: MEXICO HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 20: BRAZIL HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 21: REST OF LATIN AMERICA
HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)